Coexistence of psoriasis vulgaris and bullous disorders.
Aytekin
S
S
Inalöz
H S
HS
Harman
M
M
Akdeniz
S
S
Deveci
E
E
Inalöz
S S
SS
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D003874:Dermatitis Herpetiformis / Q000150:complications* / Q000188:drug therapy; D003937:Diagnosis, Differential; D019085:Fluorescent Antibody Technique, Direct; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000150:complications* / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use; D011565:Psoriasis / Q000150:complications*
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D003622:Dapsone; D011239:Prednisolone